Shanghai Serum Bio-Technology Co., Ltd. (688163.SS)
- Previous Close
17.18 - Open
17.19 - Bid 17.38 x --
- Ask 17.41 x --
- Day's Range
17.18 - 17.49 - 52 Week Range
11.50 - 22.92 - Volume
1,059,922 - Avg. Volume
973,607 - Market Cap (intraday)
1.884B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
40.49 - EPS (TTM)
0.43 - Earnings Date --
- Forward Dividend & Yield 0.32 (1.86%)
- Ex-Dividend Date Sep 12, 2024
- 1y Target Est
--
Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sale of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China.
www.serum-china.com.cnRecent News: 688163.SS
View MorePerformance Overview: 688163.SS
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688163.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688163.SS
View MoreValuation Measures
Market Cap
1.86B
Enterprise Value
1.06B
Trailing P/E
39.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.06
Price/Book (mrq)
1.69
Enterprise Value/Revenue
5.48
Enterprise Value/EBITDA
20.02
Financial Highlights
Profitability and Income Statement
Profit Margin
23.29%
Return on Assets (ttm)
--
Return on Equity (ttm)
4.13%
Revenue (ttm)
194.92M
Net Income Avi to Common (ttm)
45.4M
Diluted EPS (ttm)
0.43
Balance Sheet and Cash Flow
Total Cash (mrq)
851.87M
Total Debt/Equity (mrq)
0.40%
Levered Free Cash Flow (ttm)
--